Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Expands By 27.3%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, an increase of 27.3% from the February 28th total of 5,120,000 shares. Approximately 7.2% of the shares of the stock are sold short. Based on an average daily volume of 1,880,000 shares, the short-interest ratio is currently 3.5 days.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ACHC. KeyCorp decreased their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, Mizuho decreased their price target on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research report on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $52.19.

Acadia Healthcare Stock Performance

ACHC stock opened at $29.21 on Thursday. Acadia Healthcare has a 1-year low of $27.61 and a 1-year high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a 50-day moving average price of $36.28 and a 200-day moving average price of $44.06. The firm has a market cap of $2.71 billion, a PE ratio of 9.58, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in ACHC. Wellington Management Group LLP boosted its stake in Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after acquiring an additional 76,490 shares in the last quarter. FMR LLC raised its stake in Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock worth $247,045,000 after buying an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP grew its stake in Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock valued at $126,189,000 after acquiring an additional 486,395 shares during the period. JPMorgan Chase & Co. grew its stake in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after acquiring an additional 454,044 shares during the period. Finally, State Street Corp raised its position in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.